You could get her curcumin:(turmeric)

[link to www.ncbi.nlm.nih.gov]

PLoS One. 2013;8(2):e55934. doi: 10.1371/journal.pone.0055934. Epub 2013 Feb 13.
Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia.
Yu J, Peng Y, Wu LC, Xie Z, Deng Y, Hughes T, He S, Mo X, Chiu M, Wang QE, He X, Liu S, Grever MR, Chan KK, Liu Z.
Source

Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America. [email protected]
Abstract

Bioactive components from dietary supplements such as curcumin may represent attractive agents for cancer prevention or treatment. DNA methylation plays a critical role in acute myeloid leukemia (AML) development, and presents an excellent target for treatment of this disease. However, it remains largely unknown how curcumin, a component of the popular Indian spice turmeric, plays a role in DNA hypomethylation to reactivate silenced tumor suppressor genes and to present a potential treatment option for AML. Here we show that curcumin down-regulates DNMT1 expression in AML cell lines, both in vitro and in vivo, and in primary AML cells ex vivo. Mechanistically, curcumin reduced the expression of positive regulators of DNMT1, p65 and Sp1, which correlated with a reduction in binding of these transcription factors to the DNMT1 promoter in AML cell lines. This curcumin-mediated down-regulation of DNMT1 expression was concomitant with p15(INK4B) tumor suppressor gene reactivation, hypomethylation of the p15(INK4B) promoter, G1 cell cycle arrest, and induction of tumor cell apoptosis in vitro. In mice implanted with the human AML MV4-11 cell line, administration of curcumin resulted in remarkable suppression of AML tumor growth. Collectively, our data indicate that curcumin shows promise as a potential treatment for AML, and our findings provide a basis for future studies to test the clinical efficacy of curcumin - whether used as a single agent or as an adjuvant - for AML treatment.

PMID:
23457487
[PubMed - in process]
PMCID:
PMC3572185

Free PMC Article

At the URL there is a link to the whole article.

More articles here:
[link to www.ncbi.nlm.nih.gov]

[link to www.ncbi.nlm.nih.gov]

[link to www.ncbi.nlm.nih.gov]

There are more: If you go to www.pubmed.com and type in Curcumin, AML you will see more.


She can take 8 grams(16 caps) a day with 6 x 1 gram fish oil tablets. Needs to be taken all in one go or maybe twice a day. Start on 2 caps a day and build up to 16 a day. Curcumin(turmeric) is the yellow curry spice in its pure form.

You can order the curcumin from here: This one is the best:

[link to www.vitacost.com]

On special now. Meriva is a special formulation that helps absorption.

Also Sulphorane the chemical found in cruciferous vegetables-broccoli, brussel sprouts, cabbage, cauliflower inhibits cancer cells.


___________________________________________________________

As well as this, lots of green tea.It contains epigallocatechins which also help.

[link to www.ncbi.nlm.nih.gov]

Br J Haematol. 2010 Apr;149(1):55-64. doi: 10.1111/j.1365-2141.2009.08040.x. Epub 2010 Jan 20.
Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2.
Britschgi A, Simon HU, Tobler A, Fey MF, Tschan MP.
Source

Department of Clinical Research, Experimental Oncology/Haematology, Bern University Hospital, Switzerland.
Abstract

Acute promyelocytic leukaemia (APL) patients are successfully treated with all-trans retinoic acid (ATRA). However, concurrent chemotherapy is still necessary and less toxic therapeutic approaches are needed. Earlier studies suggested that in haematopoietic neoplasms, the green tea polyphenol epigallocatechin-3-gallate (EGCG) induces cell death without adversely affecting healthy cells. We aimed at deciphering the molecular mechanism of EGCG-induced cell death in acute myeloid leukaemia (AML). A significant increase of death-associated protein kinase 2 (DAPK2) levels was found in AML cells upon EGCG treatment paralleled by increased cell death that was significantly reduced upon silencing of DAPK2. Moreover, combined ATRA and EGCG treatment resulted in cooperative DAPK2 induction and potentiated differentiation. EGCG toxicity of primary AML blasts correlated with 67 kDa laminin receptor (67LR) expression. Pretreatment of AML cells with ATRA, causing downregulation of 67LR, rendered these cells resistant to EGCG-mediated cell death. In summary, it was found that (i) DAPK2 is essential for EGCG-induced cell death in AML cells, (ii) ATRA and EGCG cotreatment significantly boosted neutrophil differentiation, and 67LR expression correlates with susceptibility of AML cells to EGCG. We thus suggest that EGCG, by selectively targeting leukaemic cells, may improve differentiation therapies for APL and chemotherapy for other AML subtypes.

PMID:
20096012
[PubMed - indexed for MEDLINE] _
_____________________________________________________

Hope this can help. Worth a try. There are people taking curcumin in high doses of 8grams a day for other hematological cancers.

good luck.